Abbott introduces additional features to diabetes management app

Abbott has announced the release of its FreeStyle LibreLink application in Europe. The implementation of new features allows users to access glucose data directly from their smartphone.

The updates to the FreeStyle app eliminate the need for users to carry the additional FreeStyle Libre reader. The updates also give users the ability to receive glucose data by utilizing the phone's near-field communication (NFC) to pick up the sensor's data. Compatible with Android and iPhones, the app presents data on real-time glucose levels, eight-hour glucose history and how glucose levels are changing. Additionally, users are able to enter notes to track food, insulin, medication and exercise.  

Further features added to the app include a larger high-resolution display, text-to-speech for glucose readings, recording smaller doses of insulin and support for 26 languages. Users also will have the ability to share data with providers through the secure, cloud-based diabetes management system LibreView and LibreLinkUp.

"We're committed to bringing life-changing technology and tools to liberate people from the many hassles of diabetes management," said Jared Watkin, senior vice president of Diabetes Care, Abbott. "The FreeStyle LibreLink app is a digital health tool that integrates glucose data directly on a smartphone so everything is all in one place. This is another step forward in making glucose monitoring seamlessly fit into a patient's daily lifestyle—helping them live a fuller, healthier life."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup